benzofurocaine: used for local & conduction anesthesia in general & microsurgical procedures; no other info available 2/13/84 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 174801 |
| SCHEMBL ID | 11861610 |
| MeSH ID | M0119835 |
| Synonym |
|---|
| benzofurocaine |
| 90326-82-2 |
| SCHEMBL11861610 |
| ethyl 4-chloro-6-((dimethylamino)methyl)-5-hydroxy-2-methylbenzofuran-3-carboxylate 2,3-dihydroxysuccinate |
| AKOS030509759 |
| 2,3-dihydroxybutanedioic acid--ethyl 4-chloro-6-[(dimethylamino)methyl]-5-hydroxy-2-methyl-1-benzofuran-3-carboxylate (1/1) |
| DTXSID60920457 |
| 2,3-dihydroxybutanedioic acid;ethyl 4-chloro-6-[(dimethylamino)methyl]-5-hydroxy-2-methyl-1-benzofuran-3-carboxylate |
| Excerpt | Reference | Relevance |
|---|---|---|
| "Benzofurocaine-treated patients exhibited less extensive edema of the parotid tissues and walls of the external acoustic meatus, faster epidermisation of the trepanation cavity and retention of the neotympanum graft." | ( [Use of benzofurocaine in stimulation of regenerative processes in the surgical treatment of patients with chronic suppurative otitis media]. Evglevskiĭ, AA; Gorbonosov, IB; Semenov, FV; Volik, AK, ) | 1.29 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " The pharmacokinetic determinants of the analgesic action of benzofurocaine are the area under the pharmacokinetic curve, half-life period, and average time of drug retention in blood." | ( [The pharmacokinetic determinants of the analgesic effect of benzofurocaine in patients with burns and wounds of the joints]. Pentiuk, OO; Semenenko, IF; Stanislavchuk, MA, ) | 0.61 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.44) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (5.88%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 16 (94.12%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||